Comparison of Lipid Measurements by Clinical Chemistry and NMR Spectroscopy
Abstract
1. Introduction
2. Materials and Methods
2.1. Collection of Samples
2.2. Sample Preparation and Analysis
NMRData Acquisition
2.3. Statistical Analysis
3. Results
3.1. Comparison Between RLP and NMR Analysis for TG, TC, HDL-C, and LDL-C in Fresh Serum Samples
3.2. Comparison Between RLP and NMR Analysis for TG, TC, HDL-C, and LDL-C in Frozen–Thawed Serum Samples
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| RLP | Routine lipid profile |
| NMR | Nuclear magnetic resonance |
| CVD | Cardiovascular disease |
| TC | Total cholesterol |
| TG | Triglyceride |
| LDL | Low-density lipoproteins |
| LDL-C | LDL cholesterol |
| HDL | High-density lipoproteins |
| HDL-C | HDL cholesterol |
| LDL-P | Low-density lipoprotein particle number |
References
- Li, M.; Yang, L.; Bai, Y.; Liu, H. Analytical Methods in Lipidomics and Their Applications. Anal. Chem. 2014, 86, 161–175. [Google Scholar] [CrossRef]
- Teo, C.C.; Chong, W.P.K.; Tan, E.; Basri, N.B.; Low, Z.J.; Ho, Y.S. Advances in Sample Preparation and Analytical Techniques for Lipidomics Study of Clinical Samples. TrAC Trends Anal. Chem. 2015, 66, 1–18. [Google Scholar] [CrossRef]
- Bali, S.; Utaal, M.S. Serum Lipids and Lipoproteins: A Brief Review of the Composition, Transport and Physiological Functions. Int. J. Sci. Rep. 2019, 5, 309. [Google Scholar] [CrossRef]
- Bhargava, S.; de la Puente-Secades, S.; Schurgers, L.; Jankowski, J. Lipids and Lipoproteins in Cardiovascular Diseases: A Classification. Trends Endocrinol. Metab. 2022, 33, 409–423. [Google Scholar] [CrossRef]
- Kenneth, R.; Feingold, M. Introduction to Lipids and Lipoproteins. 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK305896/ (accessed on 9 September 2025).
- Ahotupa, M. Lipid Oxidation Products and the Risk of Cardiovascular Diseases: Role of Lipoprotein Transport. Antioxidants 2024, 13, 512. [Google Scholar] [CrossRef] [PubMed]
- Garcia, E.; Bennett, D.W.; Connelly, M.A.; Jeyarajah, E.J.; Warf, F.C.; Shalaurova, I.; Matyus, S.P.; Wolak-dinsmore, J.; Oskardmay, D.N.; Young, R.M.; et al. The Extended Lipid Panel Assay: A Clinically- Deployed High-Throughput Nuclear Magnetic Resonance Method for the Simultaneous Measurement of Lipids and Apolipoprotein B. Lipids Health Dis. 2020, 19, 247. [Google Scholar] [CrossRef]
- Matyus, S.P.; Braun, P.J.; Wolak-dinsmore, J.; Jeyarajah, E.J.; Shalaurova, I.; Xu, Y.; Warner, S.M.; Clement, T.S.; Connelly, M.A.; Fischer, T.J. NMR Measurement of LDL Particle Number Using the Vantera ® Clinical Analyzer. Clin. Biochem. 2014, 47, 203–210. [Google Scholar] [CrossRef]
- Wang, F.; Debik, J.; Andreassen, T.; Euceda, L.R.; Haukaas, T.H.; Cannet, C.; Schäfer, H.; Bathen, T.F.; Giskeødegård, G.F. Effect of Repeated Freeze-Thaw Cycles on NMR-Measured Lipoproteins and Metabolites in Biofluids. J. Proteome Res. 2019, 18, 3681–3688. [Google Scholar] [CrossRef]
- Lee, J.; Young, S.; Shin, S. Effect of Repeated Freezing and Thawing on Biomarker Stability in Plasma and Serum Samples. Osong Public Health Res. Perspect. 2015, 6, 357–362. [Google Scholar] [CrossRef]
- Loo, R.L.; Lodge, S.; Kimhofer, T.; Bong, S.H.; Begum, S.; Whiley, L.; Gray, N.; Lindon, J.C.; Nitschke, P.; Lawler, N.G.; et al. Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples. J. Proteome Res. 2020, 19, 4428–4441. [Google Scholar] [CrossRef]
- Pinto, J.; Domingues, M.R.M.; Galhano, E.; Pita, C.; Do Céu Almeida, M.; Carreira, I.M.; Gil, A.M. Human Plasma Stability during Handling and Storage: Impact on NMR Metabolomics. Analyst 2014, 139, 1168–1177. [Google Scholar] [CrossRef]
- Wist, J.; Nitschke, P.; Conde, R.; de Diego, A.; Bizkarguenaga, M.; Lodge, S.; Hall, D.; Chai, Z.; Wang, W.; Kowlessur, S.; et al. Benchtop Proton NMR Spectroscopy for High-Throughput Lipoprotein Quantification in Human Serum and Plasma. Anal. Chem. 2025, 97, 6399–6409. [Google Scholar] [CrossRef] [PubMed]
- Akoglu, H. User’s Guide to Correlation Coefficients. Turkish J. Emerg. Med. 2018, 18, 91–93. [Google Scholar] [CrossRef]
- Kwak, S.G.; Park, S.H. Normality Test in Clinical Research. J. Rheum. Dis. 2019, 26, 5–11. [Google Scholar] [CrossRef]
- Julkunen, H.; Cichońska, A.; Tiainen, M.; Koskela, H.; Nybo, K.; Mäkelä, V.; Nokso-Koivisto, J.; Kristiansson, K.; Perola, M.; Salomaa, V.; et al. Atlas of Plasma NMR Biomarkers for Health and Disease in 118,461 Individuals from the UK Biobank. Nat. Commun. 2023, 14, 604. [Google Scholar] [CrossRef]
- Nordestgaard, B.G.; Langlois, M.R.; Langsted, A.; Chapman, M.J.; Aakre, K.M.; Baum, H.; Borén, J.; Bruckert, E.; Catapano, A.; Cobbaert, C.; et al. Quantifying Atherogenic Lipoproteins for Lipid-Lowering Strategies: Consensus-Based Recommendations from EAS and EFLM. Atherosclerosis 2020, 294, 46–61. [Google Scholar] [CrossRef]
- Rief, M.; Raggam, R.; Rief, P.; Metnitz, P.; Stojakovic, T.; Reinthaler, M.; Brodmann, M.; März, W.; Scharnagl, H.; Silbernagel, G. Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations. Biomedicines 2022, 10, 1766. [Google Scholar] [CrossRef] [PubMed]
- Bathen, T.F.; Krane, J.; Engan, T.; Bjerve, K.S.; Axelson, D. Quantification of Plasma Lipids and Apolipoproteins by Use of Proton NMR Spectroscopy, Multivariate and Neural Network Analysis. NMR Biomed. 2000, 13, 271–288. [Google Scholar] [CrossRef]
- Contois, J.H.; McConnell, J.P.; Sethi, A.A.; Csako, G.; Devaraj, S.; Hoefner, D.M.; Warnick, G.R. Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin. Chem. 2009, 55, 407–419. [Google Scholar] [CrossRef]
- Davidson, M.H.; Ballantyne, C.M.; Jacobson, T.A.; Bittner, V.A.; Braun, L.T.; Brown, A.S.; Brown, W.V.; Cromwell, W.C.; Goldberg, R.B.; McKenney, J.M.; et al. Clinical Utility of Inflammatory Markers and Advanced Lipoprotein Testing: Advice from an Expert Panel of Lipid Specialists. J. Clin. Lipidol. 2011, 5, 338–367. [Google Scholar] [CrossRef] [PubMed]
- Schönbrodt, F.D.; Perugini, M. At What Sample Size Do Correlations Stabilize? J. Res. Pers. 2013, 47, 609–612. [Google Scholar] [CrossRef]
- Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Routledge: Oxfordshire, UK, 1988. [Google Scholar]
- Kim, T.K.; Park, J.H. More about the Basic Assumptions of T-Test: Normality and Sample Size. Korean J. Anesthesiol. 2019, 72, 331–335. [Google Scholar] [CrossRef] [PubMed]
- Cuhadar, S.; Koseoglu, M.; Atay, A.; Dirican, A. The Effect of Storage Time and Freeze-Thaw Cycles on the Stability of Serum Samples. Biochem. Medica 2013, 23, 70–77. [Google Scholar] [CrossRef] [PubMed]
- Abraham, R.A.; Rana, G.; Agrawal, P.K.; Johnston, R.; Sarna, A.; Ramesh, S.; Acharya, R.; Khan, N.; Porwal, A.; Kurundkar, S.B.; et al. The Effects of a Single Freeze-Thaw Cycle on Concentrations of Nutritional, Noncommunicable Disease, and Inflammatory Biomarkers in Serum Samples. J. Lab. Physicians 2021, 13, 6–13. [Google Scholar] [CrossRef] [PubMed]
- Rebholz, S.L.; Melchior, J.T.; Welge, J.A.; Remaley, A.T.; Davidson, W.S.; Woollett, L.A. Effects of Multiple Freeze/Thaw Cycles on Measurements of Potential Novel Biomarkers Associated With Adverse Pregnancy Outcomes. J. Clin. Lab. Med. 2017, 2, 10–10966. [Google Scholar] [CrossRef]




| Cholesterol (mg/dL) | ||||
|---|---|---|---|---|
| <92 | 92–200 | >200 | ||
| RLP (n) * | 17 | 8711 | 8609 | |
| NMR (n) | 8 | 5921 | 11,408 | |
| Triglyceride (mg/dL) | ||||
| <50 | 50–150 | >150 | ||
| RLP (n) | 1650 | 11,765 | 3919 | |
| NMR (n) | 1381 | 11,935 | 4018 | |
| HDL-C (mg/dL) | ||||
| <50 | >50 | |||
| RLP (n) | 7308 | 10,029 | ||
| NMR (n) | 4996 | 12,341 | ||
| LDL-C (mg/dL) | ||||
| <50 | 50–130 | >130 | ||
| RLP (n) | 96 | 9041 | 8200 | |
| NMR (n) | 127 | 8055 | 9155 | |
| RLP vs. NMR on Fresh Serum Samples | RLP vs. NMR on Frozen Serum Samples * | ||||||
|---|---|---|---|---|---|---|---|
| Level Range | Correlation Coefficient (r) | Correlation p-Value | t-Test p-Value | Correlation Coefficient (r) | Correlation p-Value | t-Test p-Value | |
| TG (mg/dL) | Total | 0.98 | <0.0001 | <0.0001 | 0.97 | <0.0001 | 0.4361696 |
| <50 | 0.48 | <0.0001 | <0.0001 | 0.50 | <0.0001 | <0.0001 | |
| 50–150 | 0.95 | <0.0001 | <0.0001 | 0.93 | <0.0001 | 0.005372 | |
| >150 | 0.96 | <0.0001 | <0.0001 | 0.89 | <0.0001 | 0.113 | |
| TC (mg/dL) | Total | 0.96 | <0.0001 | <0.0001 | 0.84 | <0.0001 | <0.0001 |
| <92 | 0.32 | 0.2102768 | 0.0001154 | 0.37 | 0.497 | 0.063 | |
| 92–200 | 0.88 | <0.0001 | <0.0001 | 0.68 | <0.0001 | <0.0001 | |
| >200 | 0.88 | <0.0001 | <0.0001 | 0.69 | <0.0001 | <0.0001 | |
| LDL-C (mg/dL) | Total | 0.93 | <0.0001 | <0.0001 | 0.83 | <0.0001 | 0.4154 |
| <50 | 0.31 | 0.00217 | 0.004029 | 0.33 | 0.0151 | 0.334 | |
| 50–130 | 0.82 | <0.0001 | <0.0001 | 0.66 | <0.0001 | <0.0001 | |
| >130 | 0.82 | <0.0001 | <0.0001 | 0.65 | <0.0001 | <0.0001 | |
| HDL-C (mg/dL) | Total | 0.95 | <0.0001 | <0.0001 | 0.86 | <0.0001 | <0.0001 |
| <50 | 0.77 | <0.0001 | <0.0001 | 0.61 | <0.0001 | <0.0001 | |
| >50 | 0.90 | <0.0001 | <0.0001 | 0.73 | <0.0001 | <0.0001 | |
| Cholesterol (mg/dL) | ||||
| <92 | 92–200 | >200 | ||
| RLP * (n a) | 6 | 4505 | 5048 | |
| NMR ** (n) | 13 | 3686 | 5860 | |
| Triglyceride (mg/dL) | ||||
| <50 | 50–150 | >150 | ||
| RLP * (n) | 783 | 6581 | 2195 | |
| NMR ** (n) | 683 | 6774 | 2102 | |
| HDL-C (mg/dL) | ||||
| <50 | >50 | |||
| RLP * (n) | 4003 | 5556 | ||
| NMR ** (n) | 3494 | 6065 | ||
| LDL-C (mg/dL) | ||||
| <50 | 50–130 | >130 | ||
| RLP * (n) | 54 | 4753 | 4752 | |
| NMR ** (n) | 113 | 4787 | 4659 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Tekin, N.; Saral, N.Y.; Toker, A.; Şahin, F.; Baykal, A.T.; Serteser, M. Comparison of Lipid Measurements by Clinical Chemistry and NMR Spectroscopy. Diagnostics 2026, 16, 28. https://doi.org/10.3390/diagnostics16010028
Tekin N, Saral NY, Toker A, Şahin F, Baykal AT, Serteser M. Comparison of Lipid Measurements by Clinical Chemistry and NMR Spectroscopy. Diagnostics. 2026; 16(1):28. https://doi.org/10.3390/diagnostics16010028
Chicago/Turabian StyleTekin, Nazlıhan, Neslihan Yıldırım Saral, Aysun Toker, Furkan Şahin, Ahmet Tarık Baykal, and Mustafa Serteser. 2026. "Comparison of Lipid Measurements by Clinical Chemistry and NMR Spectroscopy" Diagnostics 16, no. 1: 28. https://doi.org/10.3390/diagnostics16010028
APA StyleTekin, N., Saral, N. Y., Toker, A., Şahin, F., Baykal, A. T., & Serteser, M. (2026). Comparison of Lipid Measurements by Clinical Chemistry and NMR Spectroscopy. Diagnostics, 16(1), 28. https://doi.org/10.3390/diagnostics16010028

